These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9028327)

  • 1. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia.
    Selleri C; Sato T; Del Vecchio L; Luciano L; Barrett AJ; Rotoli B; Young NS; Maciejewski JP
    Blood; 1997 Feb; 89(3):957-64. PubMed ID: 9028327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis.
    Selleri C; Maciejewski JP; Pane F; Luciano L; Raiola AM; Mostarda I; Salvatore F; Rotoli B
    Blood; 1998 Aug; 92(3):981-9. PubMed ID: 9680367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.
    Carlo-Stella C; Regazzi E; Sammarelli G; Colla S; Garau D; Gazit A; Savoldo B; Cilloni D; Tabilio A; Levitzki A; Rizzoli V
    Blood; 1999 Jun; 93(11):3973-82. PubMed ID: 10339507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of FAS-mediated apoptosis in chronic myelogenous leukemia.
    Selleri C; Maciejewski JP
    Leuk Lymphoma; 2000 Apr; 37(3-4):283-97. PubMed ID: 10752980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
    Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
    Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.
    Bhatia R; McCarthy JB; Verfaillie CM
    Blood; 1996 May; 87(9):3883-91. PubMed ID: 8611716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis.
    Fogli M; Carlo-Stella C; Curti A; Ratta M; Tazzari PL; Ragazzi E; Colla S; Santucci AM; Tura S; Lemoli RM
    Exp Hematol; 2000 Jul; 28(7):775-83. PubMed ID: 10907639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
    Visani G; Russo D; Ottaviani E; Tosi P; Damiani D; Michelutti A; Manfroi S; Baccarani M; Tura S
    Leukemia; 1997 May; 11(5):624-8. PubMed ID: 9180282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.
    Maciejewski J; Selleri C; Anderson S; Young NS
    Blood; 1995 Jun; 85(11):3183-90. PubMed ID: 7538820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
    Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential mechanisms of action of interferon-alpha in CML.
    Dowding C; Gordon M; Guo AP; Maison D; Osterholz J; Siczkowski M; Goldman J
    Leuk Lymphoma; 1993; 11 Suppl 1():185-91. PubMed ID: 7504544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.
    Sato T; Selleri C; Anderson S; Young NS; Maciejewski JP
    Br J Haematol; 1997 May; 97(2):356-65. PubMed ID: 9163602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
    Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
    Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia.
    Maciejewski JP; Selleri C; Sato T; Anderson S; Young NS
    Br J Haematol; 1995 Sep; 91(1):245-52. PubMed ID: 7577642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
    Bhatia R; Wayner EA; McGlave PB; Verfaillie CM
    J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-tumor activities of interferon (IFN)-alpha in chronic myelogenous leukaemia (CML)-derived cell lines depends on the IFN-alpha subtypes.
    Yanai Y; Sanou O; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
    Cancer Lett; 2002 Nov; 185(2):173-9. PubMed ID: 12169391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro.
    Mahon FX; Chahine H; Barbot C; Pigeonnier V; Jazwiec B; Reiffers J; Ripoche J
    Leukemia; 1997 May; 11(5):667-73. PubMed ID: 9180290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological effects of interferon-alpha on chronic myelogenous leukemia.
    de Castro FA; Palma PV; Morais FR; Simões BP; Carvalho PV; Ismael SJ; Lima CP; Voltarelli JC
    Leuk Lymphoma; 2003 Dec; 44(12):2061-7. PubMed ID: 14959848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.